IRIS
CERIELLO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.773
EU - Europa 3.870
AS - Asia 2.069
SA - Sud America 384
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 3
Totale 25.133
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.702
UA - Ucraina 1.591
SG - Singapore 1.148
DE - Germania 737
FI - Finlandia 599
CN - Cina 525
BR - Brasile 351
RU - Federazione Russa 305
IE - Irlanda 251
SE - Svezia 174
KR - Corea 158
TR - Turchia 121
IT - Italia 74
CA - Canada 53
GB - Regno Unito 50
HK - Hong Kong 28
IN - India 22
FR - Francia 19
EU - Europa 14
AR - Argentina 12
BE - Belgio 12
IR - Iran 12
MX - Messico 11
IQ - Iraq 9
NL - Olanda 9
AT - Austria 8
TW - Taiwan 8
CH - Svizzera 7
PK - Pakistan 7
PT - Portogallo 7
TN - Tunisia 7
VE - Venezuela 6
PL - Polonia 5
EC - Ecuador 4
ES - Italia 4
PY - Paraguay 4
AZ - Azerbaigian 3
BD - Bangladesh 3
CL - Cile 3
CZ - Repubblica Ceca 3
HU - Ungheria 3
MA - Marocco 3
RO - Romania 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
AU - Australia 2
BS - Bahamas 2
CO - Colombia 2
DZ - Algeria 2
EE - Estonia 2
GE - Georgia 2
IL - Israele 2
JP - Giappone 2
KE - Kenya 2
KG - Kirghizistan 2
PA - Panama 2
PH - Filippine 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
ID - Indonesia 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
MM - Myanmar 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SV - El Salvador 1
TG - Togo 1
UY - Uruguay 1
VN - Vietnam 1
Totale 25.133
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.296
Fairfield 2.612
Ann Arbor 2.388
Houston 1.859
Jacksonville 1.185
Ashburn 1.098
Seattle 1.003
Wilmington 927
Cambridge 925
Dearborn 554
Chandler 528
Singapore 393
Boardman 296
Beijing 287
Princeton 265
Dublin 251
Seoul 151
San Diego 138
Izmir 116
Munich 91
Helsinki 64
Ogden 56
Norwalk 49
Ottawa 42
Des Moines 41
Hefei 37
San Mateo 35
São Paulo 35
Nanjing 30
Grafing 27
Hong Kong 27
New York 25
Kunming 22
Udine 21
Nuremberg 20
Nanchang 16
Guangzhou 13
Jinan 13
Andover 11
Belo Horizonte 11
Hull 11
Leawood 10
Los Angeles 9
Saint Petersburg 9
Wuhan 9
Brussels 8
Chongqing 8
Düsseldorf 8
Fuzhou 8
Augusta 7
Rio de Janeiro 7
Toronto 7
Campinas 6
Dallas 6
Frankfurt am Main 6
Hangzhou 6
Shenyang 6
Vienna 6
Washington 6
Zhengzhou 6
Changsha 5
Chicago 5
Hebei 5
Mexico City 5
Milan 5
San Stino di Livenza 5
Taipei 5
Zurich 5
Brasília 4
Bremen 4
Charlotte 4
Edinburgh 4
Eindhoven 4
Falls Church 4
Jyväskylä 4
Moscow 4
Porto Alegre 4
Salvador 4
Santiago 4
São José do Rio Preto 4
Tunis 4
Vicenza 4
Warsaw 4
Araras 3
Ardabil 3
Baku 3
Baotou 3
Boston 3
Brooklyn 3
Cachoeira do Sul 3
Chengdu 3
Coimbra 3
Curitiba 3
Goiânia 3
Guarda 3
Henderson 3
London 3
Magione 3
Magé 3
Monmouth Junction 3
Totale 19.258
Salva come PNG Salva come JPEG
Nome #
Deficient antithrombin III activity and enhanced fibrinolysis in patients with liver disease: Evidence against a cause-effect relationship 199
Possible role of oxidative stress in the pathogenesis of hypertension. 195
Oxidative stress and diabetes-associated complications. 173
Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat 163
Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. 144
The oxygen-release capacity of red blood cells in insulin-dependent diabetics after artificial pancreas. 143
Administration of a new diabetes-specific enteral formula results in an improved 24h glucose profile in type 2 diabetic patients. 142
Acute hyperglycaemia and oxidative stress generation. 141
High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress. 140
Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation 138
Increased prothrombin fragment 1 + 2 in type I diabetic patients. 135
Does a common mechanism induce diverse complications of diabetes? 135
The metabolic syndrome--a postprandial disease? 135
Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update. 135
Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects. 134
Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation--a preliminary report. 133
Antioxidant therapy in diabetic complications: what is new? 131
Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome. 129
Prevention of vascular events in diabetes mellitus: which "antithrombotic" therapy? 129
D-lysine and non-enzymatic glycation. 128
Atypical environmental factor in expressing type I (insulin-dependent) diabetes mellitus. 128
How do we define cure of diabetes? 127
Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study. 126
Intra-arterial iloprost for limb ischaemia. 125
Glucose metabolism and hyperglycemia. 125
Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease. 125
Postprandial glucose regulation: new data and new implications. 125
New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. 124
Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling. 124
Meal-generated oxidative stress in type 2 diabetic patients 123
Impaired glucose metabolism in heroin and methadone users. 122
Pregnancy as environmental factor precipitating IDDM. 122
Aspirin and non-enzymatic glycation. 122
Point: postprandial glucose levels are a clinically important treatment target. 122
Postprandial oxidized lipids in diabetic patients: which role for postprandial hyperglycemia? 122
Non-enzymatic glycosylation reduces antithrombin III activity 122
Fibrinogen plasma levels as a marker of thrombin activation: new insights on the role of fibrinogen as a cardiovascular risk factor 122
Non-enzymatic glycation reduces heparin cofactor II anti-thrombin activity. 122
Increased glycosylated proteins in opiate addicts. 121
Sodium salicylate restores the impaired insulin response to glucose and improves glucose tolerance in heroin addicts. 120
Opiate addict as diabetic patient? 120
Total radical-trapping antioxidant parameter in NIDDM patients. 119
Antioxidant anti-inflammatory treatment in type 2 diabetes. 119
Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. 119
Mean red blood cell volume, narcotic addiction, and glucose tolerance 119
Guideline for management of postmeal glucose. 119
Increased glycation and oxidative damage to apolipoprotein B100 of LDL cholesterol in patients with type 2 diabetes and effect of metformin. 119
Red wine protects diabetic patients from meal-induced oxidative stress and thrombosis activation: a pleasant approach to the prevention of cardiovascular disease in diabetes. 118
Tolrestat for mild diabetic neuropathy. A 52-week, randomized, placebo-controlled trial. 118
C-reactive protein is directly related to plasminogen activator inhibitor type 1 (PAI-1) levels in diabetic subjects with the 4G allele at position -675 of the PAI-1 gene. 118
A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization. 118
Consensus algorithm of the American Diabetes Association and the European Association for the Study of Diabetes: some concerns. 118
Evaluation of gliclazide ability to attenuate the hyperglycaemic 'memory' induced by high glucose in isolated human endothelial cells. 116
Optimized postprandial glucose control is associated with improved cardiac/vascular function - comparison of three insulin regimens in well-controlled type 2 diabetes. 116
Optimal dietary approaches for prevention of type 2 diabetes: a life-course perspective. 116
Meal-generated oxidative stress in diabetes. The protective effect of red wine. 115
Congestive heart failure and cognitive impairment in the elderly. 115
The role of hyperglycaemia-induced alterations of antithrombin III and factor X activation in the thrombin hyperactivity of diabetes mellitus. 115
Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. 115
Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human Umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production 115
Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects. 114
Endogenous opiates, heroin addiction, and non-insulin-dependent diabetes. 114
Inhibitory effect of enkephalin on insulin secretion in healthy subjects and in non insulin-dependent diabetic subjects. 114
Diabetes mellitus and hypertension: the possible role of hyperglycaemia through oxidative stress. 114
Effects of S 21403 (mitiglinide) on postprandial generation of oxidative stress and inflammation in type 2 diabetic patients 114
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis. 114
Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes. 113
'Glycaemic variability': a new therapeutic challenge in diabetes and the critical care setting. 113
Evidence for a reduced heparin cofactor II biological activity in diabetes. 112
Post-meal coagulation activation in diabetes mellitus: the effect of acarbose. 112
Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring. 112
Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial. 112
The preventive anti-oxidant action of thiazolidinediones: a new therapeutic prospect in diabetes and insulin resistance. 112
Post-meal glucose peaks at home associate with carotid intima-media thickness in type 2 diabetes. 111
Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus 111
Effects of salicylate, tolbutamide, and prostaglandin E2 on insulin responses to glucose in noninsulin-dependent diabetes mellitus. 111
Glycosaminoglycan therapy for long-term diabetic complications? 110
Macromolecular protein complex: a new way to understand the fibrinogen lowering effect of glycosaminoglycans? 110
Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes. 110
The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment. 110
Dual effect of beta-endorphin on insulin secretion in man. 109
Beta-endorphin and islet hormone release in humans: evidence for interference with cAMP. 109
Angiotensin-receptor blockers, type 2 diabetes, and renoprotection. 109
Glucose "peak" and glucose "spike": Impact on endothelial function and oxidative stress. 109
Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors. 109
Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation. Effects of short- and long-term simvastatin treatment 109
Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison. 108
Increased alpha 2-macroglobulin in diabetes: a hyperglycemia related phenomenon associated with reduced antithrombin III activity. 108
Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting. 107
Hypothesis: the 'metabolic memory', the new challenge of diabetes. 107
Evidence for a hyperglycaemia-dependent decrease of antithrombin III-thrombin complex formation in humans. 106
Postprandial hyperglycemia and cardiovascular disease: is the HEART2D study the answer? 106
The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose. 106
Fibrinogen levels in opiate addicts. 106
Heparin preserves antithrombin III biological activity from hyperglycemia-induced alterations in insulin-dependent diabetics. 106
Influence of labile glucose adducts on glycosylated protein assay by aminophenylboronic acid affinity chromatography: in vivo studies. 105
Is oxidative stress the missing link between insulin resistance and atherosclerosis? 105
Oxidative stress in diabetes. 105
Are there specific treatments for the metabolic syndrome? 105
International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations. 105
Totale 12.100
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.790
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.790
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020544 0 0 0 0 0 0 0 0 0 0 133 411
2020/20213.664 63 429 88 534 141 430 289 430 607 125 394 134
2021/20221.932 92 183 69 136 39 105 135 97 18 404 344 310
2022/20231.473 272 52 7 180 122 479 1 90 179 22 38 31
2023/2024324 51 30 9 5 53 47 3 10 83 14 3 16
2024/20252.688 46 292 49 81 50 159 227 192 415 603 574 0
Totale 25.176